Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Healios K.K. | 6VX | May 31, 2024 | 0.90 | +12.58 |
Hemogenyx Pharmaceuticals Plc | 5HU | May 31, 2024 | 0.02 | 0.00 |
HUTCHMED (China) Limited | H7T2 | May 31, 2024 | 3.34 | -0.60 |
Hybrigenics | 3HB | May 31, 2024 | 0.00 | -2.33 |
Hyloris Pharmaceuticals SA | 52U | May 31, 2024 | 11.40 | 0.00 |
Immupharma Plc | 25I | May 31, 2024 | 0.02 | +5.00 |
Immutep Limited | YP1B | May 31, 2024 | 0.25 | +0.79 |
Inhibrx, Inc. | 1RK | May 31, 2024 | 31.00 | 0.00 |
Innovent Biologics Inc | 6IB | May 31, 2024 | 3.96 | -0.50 |
Inventiva S.A. - American Depository Shares | 6IVA | May 31, 2024 | 3.30 | +3.13 |
Ixico Plc | PYPB | May 31, 2024 | 0.07 | 0.00 |
Legend Biotech Corporation - American Depositary Shares | 9LB | May 31, 2024 | 36.80 | -5.64 |
Mabion S.A. | 272 | May 31, 2024 | 3.79 | -1.30 |
Medesis Pharma S.A. | 76D | May 31, 2024 | 0.85 | +6.25 |
Medmira Inc | 47M | May 31, 2024 | 0.05 | 0.00 |
Memphasys Limited | IG7 | May 31, 2024 | 0.00 | 0.00 |
Mesoblast Ltd | LWB | May 31, 2024 | 0.65 | -2.99 |
Nanocarrier Co Ltd | 3NQ | May 31, 2024 | 0.71 | +2.88 |
NetScientific plc | NTK1 | May 31, 2024 | 0.70 | 0.00 |
Newron Pharmaceuticals Spa. | NP5 | May 31, 2024 | 9.89 | +0.61 |
Nuformix plc | 1RT | May 31, 2024 | 0.00 | 0.00 |
Ocumension Therapeutics | 5DG | May 31, 2024 | 0.78 | +0.65 |
Oncimmune Holdings plc | OCY | May 31, 2024 | 0.22 | -0.89 |
Oncoarendi Therapeutics SA | 1B1 | May 31, 2024 | 3.38 | -1.03 |
Oncotherpapy Science Inc | 30O | May 31, 2024 | 0.11 | -16.91 |
Open Orphan plc | CRO | May 31, 2024 | 0.30 | +0.68 |
Opthea Limited | UKJ | May 31, 2024 | 0.28 | -4.11 |
OptiBiotix Health plc | OB3 | May 31, 2024 | 0.21 | 0.00 |
Oric Pharmaceuticals, Inc. | 4TZ | May 31, 2024 | 8.40 | +7.01 |
Oxford BioDynamics plc | LMQ | May 31, 2024 | 0.05 | +2.04 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.